The Valley Desk

NCT00546780 · Interventional trial

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

Overall registry status Completed

Phase 3

Conditions Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov